secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNS Pharmaceuticals, Inc. (CNSP)
CIK:        0001729427
Form:       8-K
Filed at:   2023-01-03T23:59:59+00:00
Accession:  0001683168-23-000004
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CNS Pharmaceuticals appoints Faith Charles as independent Chair of Board
------------------------------------------------------------------------

- Faith L. Charles appointed independent Chair of Board effective Dec 30, 2022.
- Compensation: $30,000 annual retainer, plus 10-year option for 3,500 shares at $2.40, vesting monthly over 36 months.
- Charles is a partner at Thompson Hine, leading its Life Sciences practice with over 30 years of experience.
- She also serves on boards of Avenue Therapeutics and Abeona Therapeutics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729427/000168316823000004/0001683168-23-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729427/000168316823000004/cns_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer